Drugs / Vitreoscilla filiformis
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00509535 | Jan 2005 → Jun 2007 | atopic eczema | L'Oreal | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vitreoscilla filiformis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00509535 ↗ |
| Known as | pure extract of thermal plankton | “The micro-organism Vitreoscilla filiformis (Vf) was cultivated on a defined and sterile medium, expanded and isolated to constitute a biomass called "pure extract of thermal plankton".” NCT00509535 ↗ |